Biological effects of NVP-BEZ235, an orally available dual P13K/mTOR inhibitor, in human endometrial cancer cell lines in vitro Meeting Abstract

cited authors

  • Winterhoff, B., Le, J., Yin, T., Guorong, E., Dowdy, S., Gostout, B., Slamon, D., Finkler, N., Podratz, K., Konecny, G.

Publication Date

  • March 1, 2010

webpage

published in

category

start page

  • S88

end page

  • S88

volume

  • 116

issue

  • 3

WoS Citations

  • 0

WoS References

  • 0